This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Lung Cancer
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of two different combination chemotherapy regimens in treating patients who have stage IIIB or stage IV non-small cell lung cancer

Provided treatments

  • Drug: carboplatin
  • Drug: cisplatin
  • Drug: docetaxel
  • Drug: gemcitabine
  • Drug: paclitaxel
  • Drug: vinorelbine
Tris trial is registered with FDA with number: NCT00003587. The sponsor of the trial is Southwest Oncology Group and it is looking for 204 volunteers for the current phase.
Official trial title:
Randomized Phase II Trial of Carboplatin/Gemcitabine Followed By Paclitaxel or Cisplatin/Vinorelbine Followed by Docetaxel in Advanced Non-Small Cell Lung Cancer